Finance

Lists
HRMY:NASDAQ
Harmony Biosciences Holdings Inc
39,64 $
+0,18%
(+0,070) 1D
39,64 $
0,00% (0,00)
After hours
Closed: 2 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HRMY...
Open
39,78 $
High
40,62 $
Low
39,25 $
Mkt. cap
2,31 մլրդ
Avg. vol.
958,83 հզր
Volume
867,93 հզր
P/E ratio
12,83
52-wk high
43,49 $
52-wk low
25,52 $
EPS
3,09 $
Beta
1,01
Shares outstanding
58,24 մլն
No. of employees
293
Open
39,78 $
High
40,62 $
Low
39,25 $
Mkt. cap
2,31 մլրդ
Avg. vol.
958,83 հզր
Volume
867,93 հզր
P/E ratio
12,83
52-wk high
43,49 $
52-wk low
25,52 $
EPS
3,09 $
Beta
1,01
Shares outstanding
58,24 մլն
No. of employees
293
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
18 ժամ առաջ
Technical Reactions to HRMY Trends in Macro Strategies
About Harmony Biosciences Holdings Inc
CEO-
Employees293
Founded2017
Headquarters-
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to HRMY in the past 3 months
Buy
Buy
4
Hold
4
Sell
1
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for HRMY in the last 3 months.
Highest
Current 39,64 $
60,00 $ (+51,36%)
Average
44,00 $ (+11,00%)
Lowest
30,00 $ (-24,32%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Hoang
Deutsche Bank
Hold
Maintained
42,00 $
+6%
10/01/2026
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
51,00 $
+28,7%
09/25/2026
Ami Fadia
Needham
Buy
Maintained
50,00 $
+26,1%
09/24/2026
Rudy Li
Wolfe Research
Buy
Initiated
60,00 $
+51,4%
08/26/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
55,00 $
+38,7%
08/12/2026
Danielle Brill
Truist Financial
Hold
Maintained
34,00 $
-14,2%
08/05/2026
So Youn Shim
UBS
Hold
Maintained
37,00 $
-6,7%
08/05/2026
Jason Gerberry
Bank of America Securities
Sell
Reiterated
30,00 $
-24,3%
08/04/2026
Corinne Johnson
Goldman Sachs
Hold
Maintained
37,00 $
-6,7%
07/16/2026
Jay Olson
Oppenheimer
Buy
Maintained
72,00 $
+81,6%
04/22/2026
David Amsellem
Piper Sandler
Buy
Reiterated
46,00 $
+16%
04/22/2026
Andreas Argyrides
Oppenheimer
Buy
Reiterated
62,00 $
+56,4%
02/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
239,46 մլն
243,78 մլն
215,39 մլն
261,28 մլն
Cost of goods sold
59,65 մլն
68,54 մլն
44,51 մլն
63,20 մլն
Cost of revenue
59,65 մլն
68,54 մլն
44,51 մլն
63,20 մլն
Research and development expenses
54,96 մլն
49,93 մլն
69,38 մլն
46,60 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
59,36 մլն
86,74 մլն
64,20 մլն
62,17 մլն
Operating expense
114,32 մլն
136,67 մլն
133,58 մլն
108,77 մլն
Total operating expenses
173,97 մլն
205,22 մլն
178,10 մլն
171,96 մլն
Operating income
65,49 մլն
38,56 մլն
37,29 մլն
89,32 մլն
Other non operating income
-106,00 հզր
-105,00 հզր
-127,00 հզր
-53,00 հզր
EBT including unusual items
67,49 մլն
40,76 մլն
39,69 մլն
93,26 մլն
EBT excluding unusual items
67,49 մլն
40,76 մլն
39,69 մլն
93,26 մլն
Income tax expense
16,62 մլն
18,27 մլն
7,20 մլն
17,83 մլն
Effective tax rate
24,63%
44,83%
18,14%
19,12%
Other operating expenses
-
-
-
-
Net income
50,86 մլն
22,49 մլն
32,49 մլն
75,43 մլն
Net profit margin
21,24%
9,22%
15,08%
28,87%
Earnings per share
1,08
0,57
0,79
1,50
Interest and investment income
5,73 մլն
5,85 մլն
5,76 մլն
7,07 մլն
Interest expense
-3,62 մլն
-3,55 մլն
-3,23 մլն
-3,07 մլն
Net interest expenses
2,11 մլն
2,31 մլն
2,52 մլն
4,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
71,46 մլն
45,99 մլն
43,26 մլն
95,28 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps